Synonyms: ARRY-334543 | ARRY334543
Compound class:
Synthetic organic
Comment: Varlitinib selectively and reversibly binds to both EGFR and HER2 and prevents their phosphorylation and activation, and is being investigated for the treatment of some types of cancer. Some bioactivity data may be linked to the tosylate salt (PubChem CID 56842258).
This clinical candidate has completed Phase II clinical trials. Click here to view varlitinib trials registered with ClinicalTrials.gov. |
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine |
International Nonproprietary Names | |
INN number | INN |
9187 | varlitinib |
Synonyms |
ARRY-334543 | ARRY334543 |
Database Links | |
CAS Registry No. | 845272-21-1 (source: Scifinder) |
ChEMBL Ligand | CHEMBL2103842 |
GtoPdb PubChem SID | 223365980 |
PubChem CID | 42642648 |
Search Google for chemical match using the InChIKey | UWXSAYUXVSFDBQ-CYBMUJFWSA-N |
Search Google for chemicals with the same backbone | UWXSAYUXVSFDBQ |
Search PubMed clinical trials | varlitinib |
Search PubMed titles | varlitinib |
Search PubMed titles/abstracts | varlitinib |
UniChem Compound Search for chemical match using the InChIKey | UWXSAYUXVSFDBQ-CYBMUJFWSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | UWXSAYUXVSFDBQ-CYBMUJFWSA-N |